Cytoskeletal-based mechanisms differently regulate in vivo and in vitro proplatelet formation

被引:29
作者
Bornert, Alicia [1 ]
Boscher, Julie [1 ]
Pertuy, Fabien [1 ]
Eckly, Anita [1 ]
Stegner, David [2 ,3 ]
Strassel, Catherine [1 ]
Gachet, Christian [1 ]
Lanza, Francois [1 ]
Leon, Catherine [1 ]
机构
[1] Univ Strasbourg, INSERM, EFS Grand Est, BPPS UMR S 1255, Strasbourg, France
[2] Univ Hosp Wurzburg, Inst Expt Biomed, Wurzburg, Germany
[3] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany
关键词
ACUTE LYMPHOBLASTIC-LEUKEMIA; 2ND MALIGNANT NEOPLASMS; NON-HODGKIN-LYMPHOMA; CHILDHOOD-CANCER SURVIVOR; B-CELL NEOPLASMS; SUBSEQUENT NEOPLASMS; RISK; CLASSIFICATION; THERAPY; ADOLESCENTS;
D O I
10.3324/haematol.2019.239111
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets are produced by bone marrow megakaryocytes through cytoplasmic protrusions, named native proplatelets (nPPT), into blood vessels. Proplatelets also refer to protrusions observed in megakaryocyte culture (cultured proplatelets [cPPT]) which are morphologically different. Contrary to cPPT, the mechanisms of nPPT formation are poorly understood. We show here in living mice that nPPT elongation is in equilibrium between protrusion and retraction forces mediated by myosin-IIA. We also found, using wild-type and b1-tubulin-deficient mice, that microtubule behavior differs between cPPT and nPPT, being absolutely required in vitro, while less critical in vivo. Remarkably, micro tubule depolymerization in myosin-deficient mice did not affect nPPT elongation. We then calculated that blood Stokes? forces may be sufficient to promote nPPT extension, independently of myosin and microtubules. Together, we propose a new mechanism for nPPT extension that might explain contradictions between severely affected cPPT production and moderate platelet count defects in some patients and animal models.
引用
收藏
页码:1368 / 1380
页数:13
相关论文
共 39 条
[1]  
[Anonymous], 2001, PATHOLOGY GENETICS T
[2]   Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents [J].
Attarbaschi, Andishe ;
Carraro, Elisa ;
Abla, Oussama ;
Barzilai-Birenboim, Shlomit ;
Bomken, Simon ;
Brugieres, Laurence ;
Bubanska, Eva ;
Burkhardt, Birgit ;
Chiang, Alan K. S. ;
Csoka, Monika ;
Fedorova, Alina ;
Jazbec, Janez ;
Kabickova, Edita ;
Krenova, Zdenka ;
Lazic, Jelena ;
Fen, Jan Loef ;
Mann, Georg ;
Niggli, Felix ;
Miakova, Natalia ;
Osumi, Tomoo ;
Ronceray, Leila ;
Uyttebroeck, Anne ;
Williams, Denise ;
Woessmann, Wilhelm ;
Wrobel, Grazyna ;
Pillon, Marta .
HAEMATOLOGICA, 2016, 101 (12) :1581-1591
[3]   Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study [J].
Bluhm, Elizabeth C. ;
Ronckers, Ckile ;
Hayashi, Robert J. ;
Neglia, Joseph P. ;
Mertens, Ann C. ;
Stovall, Marilyn ;
Meadows, Anna T. ;
Mitby, Pauline A. ;
Whitton, John A. ;
Hammond, Sue ;
Barker, Joseph D. ;
Donaldson, Sarah S. ;
Robison, Leslie L. ;
Inskip, Peter D. .
BLOOD, 2008, 111 (08) :4014-4021
[4]   Second malignant neoplasms after a first cancer in childhood:: temporal pattern of risk according to type of treatment [J].
de Vathaire, F ;
Hawkins, M ;
Campbell, S ;
Oberlin, O ;
Raquin, MA ;
Schlienger, JY ;
Shamsaldin, A ;
Diallo, I ;
Bell, J ;
Grimaud, E ;
Hardiman, C ;
Lagrange, JL ;
Daly-Schveitzer, N ;
Panis, X ;
Zucker, JM ;
Sancho-Garnier, H ;
Eschwège, F ;
Chavaudra, J ;
Lemerle, J .
BRITISH JOURNAL OF CANCER, 1999, 79 (11-12) :1884-1893
[5]   Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study [J].
Ehrhardt, Matthew J. ;
Chen, Yan ;
Sandlund, John T. ;
Bluhm, Elizabeth C. ;
Hayashi, Robert J. ;
Becktell, Kerri ;
Leisenring, Wendy M. ;
Metzger, Monika L. ;
Ness, Kirsten K. ;
Krull, Kevin R. ;
Oeffinger, Kevin C. ;
Gibson, Todd M. ;
Cairo, Mitchell S. ;
Gross, Thomas G. ;
Robison, Leslie L. ;
Armstrong, Gregory T. ;
Yasui, Yutaka ;
Hudson, Melissa M. ;
Mulrooney, Daniel A. .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (28) :2556-+
[6]   Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study [J].
Ehrhardt, Matthew J. ;
Sandlund, John T. ;
Zhang, Nan ;
Liu, Wei ;
Ness, Kirsten K. ;
Bhakta, Nickhill ;
Chemaitilly, Wassim ;
Krull, Kevin R. ;
Brinkman, Tara M. ;
Crom, Deborah B. ;
Kun, Larry ;
Kaste, Sue C. ;
Armstrong, Gregory T. ;
Green, Daniel M. ;
Srivastava, Kumar ;
Robison, Leslie L. ;
Hudson, Melissa M. ;
Mulrooney, Daniel A. .
PEDIATRIC BLOOD & CANCER, 2017, 64 (06)
[7]   Subsequent Neoplasms in 5-Year Survivors of Childhood Cancer: The Childhood Cancer Survivor Study [J].
Friedman, Debra L. ;
Whitton, John ;
Leisenring, Wendy ;
Mertens, Ann C. ;
Hammond, Sue ;
Stovall, Marilyn ;
Donaldson, Sarah S. ;
Meadows, Anna T. ;
Robison, Leslie L. ;
Neglia, Joseph P. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (14) :1083-1095
[8]  
HARRIS NL, 1994, BLOOD, V84, P1361
[9]   New malignancies following childhood cancer in the United States, 1973-2002 [J].
Inskip, Peter D. ;
Curtis, Rochelle E. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) :2233-2240
[10]  
Kalbfleisch J.D., 1980, The Statistical Analysis of Failure Time Data, P163